Status:
COMPLETED
Diffusion Spectroscopy in Stroke
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
ISCHEMIC STROKE
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Cerebral vascular disorder is one of the most fatal diseases despite current advances in medical science. The large number of negative clinical trials on neuroprotection in acute stroke is a pointer t...
Eligibility Criteria
Inclusion
- first-ever infarct lesion Infarct volume \> 8 cm3 written consent French social security
Exclusion
- age \<18 or \>80 years contraindication to MRI Life-threatening disease that could compromise the follow-up Pregnant and breast-feeding women Patients under a legal gardian
- We will also include 24 healthy subjects for comparison with no history of neurological disease.
Key Trial Info
Start Date :
July 28 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 25 2019
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT02833961
Start Date
July 28 2016
End Date
October 25 2019
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut du cerveau et de la moelle, Hôpital Pitié-Salpétrière
Paris, France, 75013